Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | TNK2 | Q07912 | 3/20 | 0.44 |
| ▸ | LCK | P06239 | 2/20 | 0.44 |
| ▸ | JAK3 | P52333 | 1/20 | 0.44 |
| ▸ | BTK | Q06187 | 1/20 | 0.44 |
| ▸ | BRD4 | O60885 | 3/20 | 0.43 |
| ▸ | SRC | P12931 | 6/20 | 0.41 |
| ▸ | WEE1 | P30291 | 2/20 | 0.41 |
| ▸ | PAK1 | Q13153 | 2/20 | 0.41 |
| ▸ | SIK1 | P57059 | 1/20 | 0.40 |
| ▸ | SIK2 | Q9H0K1 | 1/20 | 0.40 |
| ▸ | SIK3 | Q9Y2K2 | 1/20 | 0.40 |
| ▸ | MET | P08581 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30962728 | 0.94 | TNK2 (0.42) | KCNH2TNK2LCKJAK3BRD4 | |
| SCHEMBL30962767 | 0.94 | TNK2 (0.48) | TNK2BRD4SRCWEE1PAK1 | |
| SCHEMBL30962585 | 0.91 | SRC (0.44) | TNK2LCKJAK3BRD4SRC | |
| SCHEMBL27313554 | 0.90 | WEE1 (0.51) | TNK2LCKJAK3BRD4SRC | |
| SCHEMBL30962787 | 0.90 | WEE1 (0.51) | TNK2LCKJAK3BRD4SRC | |
| SCHEMBL30962615 | 0.87 | WEE1 (0.48) | TNK2LCKJAK3BRD4SRC | |
| SCHEMBL30962751 | 0.87 | WEE1 (0.48) | TNK2LCKJAK3BRD4SRC | |
| SCHEMBL30962620 | 0.87 | WEE1 (0.48) | TNK2LCKJAK3BRD4SRC | |
| SCHEMBL30962914 | 0.86 | WEE1 (0.46) | TNK2LCKJAK3SRCWEE1 | |
| SCHEMBL30962935 | 0.86 | WEE1 (0.46) | TNK2LCKJAK3SRCWEE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642767-A1 | PYRIMIDINE CARBOXAMIDE COMPOUNDS | Acrivon Therapeutics, Inc. (US) | 2025-11-05 | — | — | EP | disclosed |